<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04808856</url>
  </required_header>
  <id_info>
    <org_study_id>ACTH</org_study_id>
    <nct_id>NCT04808856</nct_id>
  </id_info>
  <brief_title>Treatment of Refractory Gout With ACTH or Methylprednisolone</brief_title>
  <official_title>Treatment of Refractory Gout With Adrenocorticotropic Hormone or Methylprednisolone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai 10th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai 10th People's Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To clarify the therapeutic effect and safety evaluation of ACTH in refractory gouty arthritis&#xD;
      and special population, and to explore its mechanism of action.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When patients with acute gout have multiple comorbidities and complications , traditional&#xD;
      treatment methods are often contraindicated . From the current clinical research evidence ,&#xD;
      we have seen the non-inferior effect of ACTH on glucocorticoids and non-steroidal&#xD;
      anti-inflammatory drugs in the treatment of acute gout , as well as the good safety and&#xD;
      extensive anti-inflammatory effect in addition to efficacy . Therefore , we designed this&#xD;
      study to update and improve the treatment of acute gout attacks , and to try to clarify the&#xD;
      mechanism of action .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of pain</measure>
    <time_frame>7 days</time_frame>
    <description>Visual analogue scale (VAS 0-10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arthritis score</measure>
    <time_frame>7 days</time_frame>
    <description>Arthritis (redness and swelling fever 0-3) score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recurrence rate</measure>
    <time_frame>1 month</time_frame>
    <description>Recurrence rate (3d, 7d, 2w, 1m follow-up; recurrence within 1m was defined as recurrence)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Gout</condition>
  <arm_group>
    <arm_group_label>ACTH</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Adrenocorticotropic Hormone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methylprednisolone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Methylprednisolone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Adrenocorticotropic Hormone</intervention_name>
    <description>Adrenocorticotropic Hormone Injection 25u qd iv *3d</description>
    <arm_group_label>ACTH</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methylprednisolone Injection</intervention_name>
    <description>Methylprednisolone Injection 40mg qd iv *3d</description>
    <arm_group_label>Methylprednisolone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  (123 items and 1 item from 4-7 are met simultaneously) :&#xD;
&#xD;
               1. Meet the 2015 ACR/EULAR classification diagnostic criteria for gout&#xD;
&#xD;
               2. Acute gouty arthritis&#xD;
&#xD;
               3. Age â‰¥18&#xD;
&#xD;
               4. Repeated attacks and prolonged pain (more than 1 month);&#xD;
&#xD;
               5. poor response or intolerance to colchicine or NSAIDs;&#xD;
&#xD;
               6. Liver and kidney dysfunction;&#xD;
&#xD;
               7. Old age;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1) History of gastrointestinal bleeding and active ulcer 2) The application history of&#xD;
             glucocorticoids and ACTH in 1 month before screening 3) Pregnancy and lactation 4)&#xD;
             Drug and alcohol abuse 5) Malignant tumor (treated or untreated within 5 years) 6)&#xD;
             Mental illness inability to communicate or have language barriers and inability to&#xD;
             fully understand and cooperate 7) negligent compensatory heart failure, unstable&#xD;
             angina pectoris, stroke, transient ischemic attack, myocardial infarction, and severe&#xD;
             arrhythmia occurred within 6 months 8) The investigator did not consider it&#xD;
             appropriate to participate in the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shen Qu, M.D Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Tenth People' Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hang Sun, MD</last_name>
    <phone>86-21-66301004</phone>
    <email>sunhang1027@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shen Qu, M.D Ph.D</last_name>
    <phone>86-21-66301004</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Shanghai Tenth People's hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200070</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hang Sun, MD</last_name>
      <phone>86-21-66301004</phone>
      <email>sunhang1027@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>March 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 19, 2021</last_update_submitted>
  <last_update_submitted_qc>March 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai 10th People's Hospital</investigator_affiliation>
    <investigator_full_name>Zhang Manna</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gout</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Methylprednisolone</mesh_term>
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Adrenocorticotropic Hormone</mesh_term>
    <mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
    <mesh_term>beta-Endorphin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

